Log in or Sign up for Free to view tailored content for your specialty!
Hematology News
NIH initiative takes ‘multiple-shots’ approach toward cure for sickle cell disease
The NIH launched an initiative to coordinate and accelerate research into a cure for sickle cell disease.
ASH's comprehensive guidelines aim to improve management of venous thromboembolism
ASH, in collaboration with the McMaster University GRADE Centre, published the first six chapters of the ASH Clinical Practice Guidelines on Venous Thromboembolism to improve the diagnosis, treatment and management of blood clots, the society announced in a press event.
Log in or Sign up for Free to view tailored content for your specialty!
FDA approves Gamifant, the first drug to treat hemophagocytic lymphohistiocytosis
The FDA has approved emapalumab for the treatment of both pediatric and adult patients with primary hemophagocytic lymphohistiocytosis who have refractory, recurrent or progressive disease or had an inadequate response or intolerance to conventional therapy, according to a press release.
Denosumab effective in transfusion-dependent thalassemia-induced osteoporosis
A twice-yearly injection of denosumab improved spinal bone mineral density among individuals with osteoporosis caused by transfusion-dependent thalassemia, according to a randomized phase 2b study published in Blood Advances.
Treatment of ‘terribly disabling’ porphyria complicated by disease rarity, misdiagnosis
Clinicians are hoping an RNA interference therapeutic targeting aminolevulinic acid synthase 1, known as givosiran, will be the answer for many patients suffering from severe attacks and symptoms related to acute hepatic porphyria.
FDA approves Promacta for first-line treatment of severe aplastic anemia
The FDA expanded the approval of eltrombopag to include the first-line treatment of patients with severe aplastic anemia.
Computer tool increases safe outpatient management of pulmonary embolism
An internet-based clinical decision support system allowed physicians to quickly and easily identify patients with pulmonary embolism eligible for home treatment without the risk of rehospitalization or major adverse events, according to findings published in Annals of Internal Medicine.
Tool improves management of patients with sickle cell disease in primary care
A clinical decision support tool that detected potential transfusional iron overload improved management of adult patients with sickle cell disease in primary care, according to findings recently published in the Journal of the American Board of Family Medicine.
Rutgers Cancer Institute section chief receives distinguished service award
Richard Drachtman, MD, received the Distinguished Service Award from Melvyn H. Motolinsky Research Foundation, established to support research into leukemia and other blood-related diseases.
Four elected to ASH executive committee
Four individuals have been elected to American Society of Hematology’s executive committee.